Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Andrea BagánLaboratory of Medicinal Chemistry, Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Fo Sciences, University of Barcelona, Av. Joan XXIII, 27-31, 08028 Barcelona, Spain.
Alba López-RuizLaboratory of Medicinal Chemistry, Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Fo Sciences, University of Barcelona, Av. Joan XXIII, 27-31, 08028 Barcelona, Spain.
Sònia AbásLaboratory of Medicinal Chemistry, Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Fo Sciences, University of Barcelona, Av. Joan XXIII, 27-31, 08028 Barcelona, Spain.ORCID 0000-0002-3005-3539
Elies MolinsInstitut de Ciència de Materials de Barcelona (CSIC), Campus UAB, 08193 Cerdanyola del Vallés, Spain.ORCID 0000-0003-1012-0551
Belén PérezDepartment of Pharmacology, Therapeutic and Toxicology, Autonomous, University of Barcelona, 08193 Cerdanyola del Vallés, Spain.ORCID 0000-0001-5801-1704
Itziar Muneta-ArrateDepartment of Pharmacology, University of the Basque Country (UPV/EHU), 48940 Leioa, Bizkaia, Spain.
Luis F CalladoDepartment of Pharmacology, University of the Basque Country (UPV/EHU), 48940 Leioa, Bizkaia, Spain.
Carmen EscolanoLaboratory of Medicinal Chemistry, Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Fo Sciences, University of Barcelona, Av. Joan XXIII, 27-31, 08028 Barcelona, Spain.ORCID 0000-0002-9117-8239
Funding
Generalitat de Catalunya 2021 SGR 00357Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación Spain, PID2022-1380790B-I00 MICIU/AEI /10.13039/501100011033 and FEDER, UE and PDC2022-133441-I00 MICIU/AEI /10.13039/501100011033 Europea Next Genera-tionEU/ PRTRthe Basque Government IT1512/22
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Synthesis of Diversely Substituted Diethyl (Pyrrolidin-2-Yl)Phosphonates. · full record | Socratic